CVS Health Co. (NYSE:CVS) Stock Holdings Lifted by Breakwater Capital Group

Breakwater Capital Group raised its position in CVS Health Co. (NYSE:CVS) by 7.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,401 shares of the pharmacy operator’s stock after purchasing an additional 491 shares during the quarter. Breakwater Capital Group’s holdings in CVS Health were worth $590,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Atticus Wealth Management LLC lifted its position in shares of CVS Health by 149.0% in the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after buying an additional 219 shares during the last quarter. USA Financial Formulas lifted its position in shares of CVS Health by 573.2% in the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 321 shares during the last quarter. Ables Iannone Moore & Associates Inc. acquired a new stake in shares of CVS Health in the fourth quarter worth about $32,000. Creekmur Asset Management LLC acquired a new stake in shares of CVS Health in the fourth quarter worth about $34,000. Finally, Steph & Co. lifted its position in shares of CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insider Buying and Selling

In other CVS Health news, Director Edward J. Ludwig purchased 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The shares were acquired at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the transaction, the director now directly owns 21,630 shares in the company, valued at $1,165,424.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.24% of the stock is owned by corporate insiders.

CVS Health Trading Up 1.2 %

CVS stock opened at $59.06 on Monday. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25. The firm has a market cap of $74.14 billion, a P/E ratio of 10.38, a P/E/G ratio of 0.56 and a beta of 0.52. The business’s 50 day moving average is $59.56 and its 200-day moving average is $70.13. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The business had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm’s revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the company earned $2.20 earnings per share. Equities analysts anticipate that CVS Health Co. will post 7.02 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. Bank of America reduced their price target on CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Piper Sandler boosted their price objective on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, March 15th. Baird R W raised CVS Health to a “hold” rating in a research report on Thursday, May 30th. JPMorgan Chase & Co. cut their price objective on CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. Finally, Truist Financial reissued a “buy” rating and set a $66.00 price objective (down previously from $90.00) on shares of CVS Health in a research report on Thursday, May 2nd. Eleven investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and a consensus target price of $75.05.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.